IRF5 as a potential immunological biomarker in lung adenocarcinoma

Shifu Li(Guangzhou First People's Hospital), Meiling Zhao(Guangzhou First People's Hospital), Roberto Díaz‐Peña(Universidad Autónoma de Chile), Alice Mogenet(Centre National de la Recherche Scientifique), Xiaofei Cao(University of Chinese Academy of Sciences)
Translational Cancer Research
December 1, 2024
Cited by 1


Related Papers